There are a few questions that seem to come up with almost every extended conversation about Kimer Med and what we’re doing. This isn’t meant to be an investor disclosure document, or anything like that; it’s just an informal discussion…
Some time ago, the folks at openphilanthropy.org posted a long article with their objections against DRACO. I can’t say I’m thrilled about the idea of posting and discussing a link with so much misinformation in it, but it’s better to just address it head-on.
Let’s start with how human cells normally defend themselves against viruses. One way this works is through antibodies. These large, Y-shaped proteins are produced by plasma B cells, a type of white blood cell. Antibodies attach to certain pathogens, effectively…